Resuscitation
Volume 81, Issue 3 , Pages 337-342, March 2010

Can early serum levels of S100B protein predict the prognosis of patients with out-of-hospital cardiac arrest?☆☆

  • Kyoung Jun Song

      Affiliations

    • Department of Emergency Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
  • ,
  • Sang Do Shin

      Affiliations

    • Department of Emergency Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
    • Corresponding Author InformationCorresponding author at: Department of Emergency Medicine, Seoul National University College of Medicine, 101 Daehakro, Jongno-Gu, Seoul 110-744, Republic of Korea. Tel.: +82 2 2072 3257; fax: +82 2 741 7855.
  • ,
  • Marcus Eng Hock Ong

      Affiliations

    • Department of Emergency Medicine, Singapore General Hospital, Singapore, Singapore.
  • ,
  • Joong Sik Jeong

      Affiliations

    • Department of Emergency Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea.

Seoul National University College of Medicine, 101 Daehak-Ro, Chongno-Gu, Seoul 110-744, Republic of Korea

Received 5 August 2009; received in revised form 8 October 2009; accepted 9 October 2009. published online 04 January 2010.

Abstract 

Objective

This study aims to know if the level of S100B protein at the initiation of cardiopulmonary resuscitation (CPR) and immediately after return of spontaneous circulation (ROSC) can predict clinical outcome.

Materials and methods

A prospective observational study from December 2004 to October 2006 was conducted in an urban tertiary hospital emergency department. Clinical demographics for out-of-hospital cardiac arrest patients were collected based on the Utstein style. Outcomes collected included ROSC for 20min, survival to admission, survival and Glasgow Outcome Scale (GOS) at 1 month. S100B protein was measured twice before starting CPR (first S100B) and immediately after ROSC (second S100B). We investigated the association between S100B protein levels and clinical outcomes using a multivariate logistic regression model.

Results

A total of 151 patients were included (age: 60.2±16.8 years, male: 64.2%). Of these, 60 (39.7%) had ROSC and 46 (30.5%) survived to admission. After 1 month, 12 (8.0%) survived and only three patients showed good GOS (≥4 points). The S100B levels were not different for ROSC, survival to admission and 1-month survival between survivors and non-survivors (p>0.05, first and second S100 B level). For the witnessed out-of-hospital cardiac arrest (OHCA) group (N=87), only the first S100B (1.22±0.85μgl−1 vs. 3.91±4.25μgl−1, p<0.001) showed significant difference for 1-month survival between survivors and non-survivors. The first S100B showed significant association with survival to emergency department (ED) but not 1-month survival (adjusted odds ratio (OR)=0.905, 95% confidence interval=0.821–0.998).

Conclusion

Higher levels of S100B at start of CPR were significantly associated with lower survival to admission, and not for 1-month survival.

Keywords: S100 protein, Cardiac arrest, Resuscitation, Outcome

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 A Spanish translated version of the abstract of this article appears as Appendix in the final online version at doi:10.1016/j.resuscitation.2009.10.012.

☆☆ This study was financially supported by the Seoul National University Hospital Clinical Research Fund (2006).

 Sang Do Shin was invited to be present in the expert panel consensus meeting on S100 protein, which was hosted and financially supported by Roche Ltd. (Switzerland) in 2008. Shin presented the result of this study there.

PII: S0300-9572(09)00539-5

doi:10.1016/j.resuscitation.2009.10.012

Resuscitation
Volume 81, Issue 3 , Pages 337-342, March 2010